MESTOPRO 25 MG

Oral androgenic compound with dihydrotestosterone-related activity; used medically in selected androgen-deficiency conditions in some markets.

Medical Purpose: Prescribed in several countries to treat conditions related to androgen deficiency in adult males:

1. Male hypogonadism (low testosterone)
2. Reduced libido, fatigue, or mood disturbances associated with androgen deficiency
3. Certain types of male infertility associated with low androgen levels

Mechanism: Binds directly to androgen receptors to replace missing testosterone. Like drostanolone, it cannot be converted into estrogen.

Key Risks: Oily skin, acne, mood changes, liver enzyme alterations, and potential impacts on lipid profiles. It is contraindicated in cases of prostate cancer or severe liver disease.

Mestopro 25 (containing Mesterolone 25 mg) is an oral androgen and anabolic steroid (AAS) derived from dihydrotestosterone (DHT). Globally, its active ingredient is best known under the original pharmaceutical brand name Proviron.

Because Mestopro 25 is primarily manufactured in South Asia (e.g., India) and traded internationally, its medical purpose, regulatory standing, and off-label usage vary by country and region.

1. Primary Medical Indications (Global Standard)

In medical systems where Mesterolone is approved, its core clinical purposes include:

1. Male Hypogonadism & Testosterone Deficiency: Supplements low endogenous testosterone levels to relieve fatigue, mood changes, loss of muscle tone, and reduced drive caused by primary testicular or secondary pituitary dysfunction.
2. Male Infertility: Prescribed off-label or in specific fertility protocols to help improve sperm quality, sperm count, and motility (though its efficacy in fertility treatment remains clinically debated).
3. Potency & Libido Support: Restores sexual function and libido in men suffering from androgen deficiency.

Unlike many oral steroids, Mesterolone does not convert into estrogen (no aromatization) and generally causes less suppression of the body's natural gonadotropin production at therapeutic doses.

2. Country-Wise Regulatory & Clinical Overview

India & South Asia (Country of Origin)

1. Status: Manufactured and sold under brand names such as Mestopro 25, Mestoviron 25, Provironum, and generic Mesterolone 25 mg.
2. Medical Practice: Prescribed by endocrinologists and urologists as a prescription-only drug for male hypogonadism and specific androgenic deficiency states.

United Kingdom, European Union & Australia

1. Status: Historically approved and marketed (as Proviron) in many European countries.
2. Usage: Prescribed under specialist supervision for androgen deficiency and age-related decline in male hypogonadism. However, some Western European regions have scaled back its routine use in favor of direct testosterone replacement.